JNPR
50
-6
MAS
52
-4
PYPL
52
-2
IRM
41
3
KIM
72
2
EMR
71
-3
MSFT
46
-11
NEM
40
3
SNA
70
-5
MMM
35
-5
RRC
52
-6
HUM
41
-4
APH
65
-3
AMAT
33
-13
CRM
60
-7
RCL
83
-2
CL
54
3
STT
64
2
EQR
54
3
ADSK
66
-4
JNPR
50
-6
MAS
52
-4
PYPL
52
-2
IRM
41
3
KIM
72
2
EMR
71
-3
MSFT
46
-11
NEM
40
3
SNA
70
-5
MMM
35
-5
RRC
52
-6
HUM
41
-4
APH
65
-3
AMAT
33
-13
CRM
60
-7
RCL
83
-2
CL
54
3
STT
64
2
EQR
54
3
ADSK
66
-4
Financhill
Back

Evaxion Biotech AS Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Sell
1

EVAX
Evaxion Biotech AS

Last Price:
1.38
Seasonality Move:
-39.48%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Evaxion Biotech AS Price Quote

$1.38
-0.06 (-4.17%)
(Updated: November 18, 2024 at 10:30 AM ET)

Evaxion Biotech AS Key Stats

Sell
1
Evaxion Biotech AS (EVAX) is a Sell
Day range:
$1.40 - $1.70
52-week range:
$1.40 - $13.61
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.00
P/B ratio:
108.55%
Volume:
75K
Avg. volume:
31K
1-year change:
-80.67%
Market cap:
$8M
Revenue:
$73K
EPS:
$-2.8

How Much Does Evaxion Biotech AS Make?

Is Evaxion Biotech AS Growing As A Company?

Data Unavailable

Evaxion Biotech AS Stock Price Performance

What Is Evaxion Biotech AS 52-Week High & Low?

Evaxion Biotech AS Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Evaxion Biotech AS?

Is Evaxion Biotech AS Cash Flow Positive?

Data Unavailable

Evaxion Biotech AS Return On Invested Capital

  • Is Management Doing A Good Job?
    EVAX return on invested capital is -238.97%
  • What Is Evaxion Biotech AS Return On Assets?
    ROA measures how assets are converting to revenues and is -69.51%
  • What Is EVAX Return On Equity?
    ROE is a measure of profitability and is 0%

Evaxion Biotech AS Earnings Date & Stock Price

Evaxion Biotech AS Competitors

  • Who Are Evaxion Biotech AS's Competitors?
    Below is a list of companies who compete with Evaxion Biotech AS or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Akari Therapeutics PLC (AKTX)
    • Ascendis Pharma AS (ASND)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • DBV Technologies SA (DBVT)

Evaxion Biotech AS Dividend Yield

Evaxion Biotech AS Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 66.67%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.56
Upside from Last Price: 702.95%

Major Shareholders

  • How many EVAX shares are owned by institutional investors?
    456.7K EVAX shares are owned by institutional investors
  • How many EVAX shares are owned by insiders?
    0 EVAX shares are owned by insiders